References
- Anders M. W., Sunram J. M. Mechanism of the metabolism of 1,3-benzodioxoles to carbon monoxide. Biochemical Pharmacology 1983; 33: 577–580
- Beaumont K. C., Macrae P. V., Miller C. M., Wright P. A., Smith D. A. Pharmacokinetics of zamifenazin in man and animals: species differences in plasma protein binding. British Journal of Clinical Pharmacology 1994; 38: 179
- Haddock R. E., Johnson A. M., Langley P. F., Nelson D. R., Pope J. A., Thomas D. R., Woods F. R. Metabolic pathway of paroxetine in animals and man and the comparative pharmacological profile of its metabolites. Acta Psychiatrica Scandinavica 1989; 80(suppl. 350)24–26
- Kamienski F. X., Casida J. E. Importance of demethylenation in the metabolism in vivo and in vitro of methylenedioxyphenyl synergists and related compounds in mammals. Biochemical Pharmacology 1970; 19: 91–112
- Kaye C. M., Haddock R. E., Langley P. F., Mellows G., Tasker T. C. G., Zussman B. D., Greb W. H. A review of the metabolism and pharmacokinetics of paroxetine in man. Acta Psychiatrica Scandinavica 1989; 80(suppl. 350)60–75
- Moreland T. A., Astoin J., Lepage F., Tombret F., Levy R. H., Baillie T. A. The metabolic rate of stiripentol in man. Drug Metabolism and Disposition 1986; 14: 654–662
- Scheline R. R. Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacological Reviews 1973; 25: 451–523
- Smith D. A. Aromatic hydroxylation of arylalkylamines in rodents. Drug Metabolism Reviews 1991; 23: 255
- Wallis R. M., Alker D. A., Burges R. A., Cross P. E., Newgreen D. T., Quinn P. Zamifenacin: a novel gut-selective muscarinic receptor antagonist. British Journal of Pharmacology 1993; 109: 36